Objective:To research PHA-CIK cells' phenotype and cytotoxicity .
目的:探讨PHA-CIK细胞的免疫表型和细胞毒活性。
Objective: to investigate the level of cytokine excreted by CIK cells in vitro.
目的:探讨CIK细胞在培养诱导过程中分泌的细胞因子水平。
CONCLUSION: CIK cells have strong proliferative ability and higher cytotoxicity to tumor cells in vitro, which could be used as a potential anti-tumor adoptive immunotherapy in clinic.
结论:CIK细胞在体外扩增能力强,对肿瘤细胞的杀伤活性高,有望成为新一代抗肿瘤过继免疫细胞制剂而应用于临床。
Hence, dendritic cells (DC) were cultured and engineered to present tumor antigens to CIK cells hoping that this might enhance the recognition of tumor cells and its subsequent killing.
因此,树突状细胞(DC细胞)递呈肿瘤抗原给共培养的CIK细胞,希望可以增强CIK细胞识别肿瘤的能力以及提高其肿瘤杀伤活性。
Objective to investigate the cytotoxicity and mechanism of killing tumor of cytokine-induced killer (CIK) cells in vitro.
目的探讨细胞因子诱导的杀伤细胞(CIK)体外杀伤活性及杀瘤机制。
Methods Co-culture tumor antigen-sensitized dendritic cells (DCs) with cytokine induced killer (CIK) cells, analyze the immune epitope and determine the killing effect on tumor cells by MTT method.
方法采用肿瘤抗原致敏的DC与CIK细胞共培养,分析其免疫表型,并用mtt染色法检测其对肿瘤细胞的杀伤力。
Methods Co-culture tumor antigen-sensitized dendritic cells (DCs) with cytokine induced killer (CIK) cells, analyze the immune epitope and determine the killing effect on tumor cells by MTT method.
方法采用肿瘤抗原致敏的DC与CIK细胞共培养,分析其免疫表型,并用mtt染色法检测其对肿瘤细胞的杀伤力。
应用推荐